期刊文献+

维A酸类药物化学预防非黑素皮肤肿瘤

Retinoids in chemoprevention of non-melanoma skin cancer
原文传递
导出
摘要 维A酸类药物因其抗肿瘤效应用于非黑素皮肤肿瘤的化学预防。异维A酸与阿维A均能有效降低非黑素皮肤肿瘤的发生。根据适应证用维A酸类药物进行化学预防时,推荐从低剂量开始逐渐增加剂量,达到能耐受的最小有效维持剂量,并根据疗效、临床耐受性等调整治疗剂量。维A酸类药物化学预防的可能机制是激活维A酸受体及维A酸x受体并影响其表达,调节转录因子活化因子-1及影响信号通路B—Raf/Mek/Erk、Stat3及核因子-KB等,调节细胞周期、诱导细胞凋亡。 Retinoids have been used for chemoprevention of nonmelanoma skin cancer (NMSC) because of their anti-cancer properties. Both isotretinoin and acitretin can effectively reduce the incidence of NMSC. When administrated for chemoprevention, the dose of retinoids should be low at the beginning, increased step by step to a tolerated minimum maintenance value, and adjusted according to clinical response and tolerance. Retinoids may exert their chemopreventive effects likely by activating retinoic acid receptors and retinoid X receptors and influencing their expressions, regulating the nuclear transcription factor activator protein-1 (AP-1) and inhibiting many signaling pathways including B-Raf/Mek/Erk, Stat3 and nuclear factor- kappa B. Furthermore, retinoids could trigger cell cycle and induce cell apoptosis.
出处 《国际皮肤性病学杂志》 2013年第4期232-234,共3页 International Journal of Dermatology and Venereology
关键词 皮肤肿瘤 维甲酸 药物制剂 化学预防 Skin neoplasms Tretinoin Pharmaceutical preparations Chemoprevention
  • 相关文献

参考文献20

  • 1Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg, 2011, 30( 1 ): 3-5. 被引量:1
  • 2Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol, 2012, 166(5): 1069-1080. 被引量:1
  • 3Otley CC, Stasko T, Tope WD, et al. Chemoprevention of nonmelanoma skin cancer with systemic retinoi ds: practical dosing and management of adverse effects. Dermatol Surg, 2006, 32(4): 562-568. 被引量:1
  • 4Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg, 2012, 38(10): 1622-1630. 被引量:1
  • 5Zavos G, Karidis NP, Tsourouflis G, et al. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736transplantations. Int J Dermatol, 2011, 50(12): 1496-1500. 被引量:1
  • 6Kadakia KC, Barton DL, Loprinzi CL, et al. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer, 2012, 118(8): 2128-2137. 被引量:1
  • 7Clouser MC, Roe D J, Foote JA, et al. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence. Nutr Cancer, 2010, 62(8): 1058-1066. 被引量:1
  • 8Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol, 2005, 152 (3): 518-523. 被引量:1
  • 9Harwood CA, Leedham-Green M, Leigh IM, et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol, 2005, 141 (4): 456-464. 被引量:1
  • 10So PL, Lee K, Hebert J, et al. Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptchl mice exposed to ultraviolet or ionizing radiation. Cancer Res, 2004, 64 (13): 4385-4389. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部